Organisation paid for research Program year 2025 Source: CMS Open Payments

Austin Heart

Neither a doctor nor a teaching hospital

Research payments

$456,181

75 payments

Through program year 2025, Austin Heart is reported as receiving $456,181 in research payments, across 75 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$86,957	26
2024	Research	$84,899	25
2023	Research	$183,560	11
2022	Research	$8,008	1
2021	Research	$25,159	1
2020	Research	$2,973	1
2019	Research	$64,625	10

Breakdown

Who paid Research payments · program years 2019–2025

Endotronix, Inc. $170,898 5 payments
CVRx, Inc. $138,946 34 payments
Impulse Dynamics (USA) Inc. $47,028 20 payments
Atricure, Inc. $45,654 4 payments
Bayer HealthCare Pharmaceuticals Inc. $28,664 2 payments
Shockwave Medical, Inc $14,344 4 payments
Merck Sharp & Dohme Corporation $7,600 3 payments
Amgen Inc. $2,925 2 payments
Boehringer Ingelheim International GmbH $122 1 payment

Studies the money was for Research payments · program years 2019–2025

Proactive-Hf $123,304 2 payments
Study name not reported $109,108 20 payments
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) $43,528 18 payments
Left Atrial Appendage Ligation With the Lariat Suture Delivery System As Adjunctive Therapy to Pulmonary Vein Isolation for Persistent Or Longstanding Persisten Atrial Fibrillation $35,154 1 payment
Proactive-Hf $33,167 2 payments
Study name not reported $29,838 14 payments
Confirmation Study #22563 $14,832 1 payment
Proactive-Hf $14,428 1 payment
Disrupt PAD III $14,344 4 payments
Finality Study #22618 $13,832 1 payment

What the money was spent on Research payments · program years 2019–2025

Patient care $53,829 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.